sequenced.`3 The putative protein coded for by the cDNA for the cystic fibrosis locus consists of 1480 amino acids. The trinucleotide codon for the 508th amino acid from the N terminus (phenylalanine) was found to be deleted in 70% of patients with cystic fibrosis. On the basis of analogy and homology a tentative structure for the protein coded for by the gene has been deduced (figure 1). The protein has been named the cystic fibrosis transmembrane regulator.
This protein has two related motifs, each consisting of six membrane spanning regions joined by a long polypeptide chain. It is proposed that very little (5%) of the protein is exposed externally and that some 80% is in the cytosol. Two features of the cytosolic domain are important. The first is a highly charged R domain with 16 potential sites for phosphorylation and the second two nucleotide binding folds, which may bind or even hydrolyse ATP. The phenylalanine deletion (AF508) occurs in the first nucleotide binding fold.
Other proteins with similar structures and a fair degree of homology are already known, principally the P glycoproteins or multiple drug resistance (MDR) proteins. These proteins are responsible for the energy dependent efflux of cytotoxic drugs from cells. Increased expression of multiple drug resistance proteins after exposure to cytotoxic Figure 1 Hypothetical structure of the cysticfibrosis transmembrane regulator. Two sets of six membrane spanning domains arejoined by a long polypeptide chain. Two nucleotide bindingfolds (NBF) bind A TP. In cysticfibrosis the missing phenylalanine is in the nucleotide bindingfold nearest to the N terminus. The R domain contains 16 potential phosphorylation sites. Note that very little of the protein is exposed to the external (upper) surface of the cell. drugs may be a major cause of drug resistance in cancer chemotherapy.4
Transepithelial ion transport in the respiratory system What goes awry in the respiratory system in cystic fibrosis and how is this related to the presence of the cystic fibrosis transmembrane regulator protein with phenylalanine deleted at position 508? It is obvious, but worth restating, that biological systems have no way of pumping water. Water can be made to move across biological barriers only by osmosis-provided, of course, that the barriers are water permeable. Movement of fluid therefore depends on solute transport, usually of inorganic ions. In the lungs surface liquid elaborated in the alveoli and small airways is moved by ciliary action to more proximal regions. As fluid does not accumulate in the proximal regions even though there is a Figure 2 Models of electrogenic sodium absorption (a) and electrogenic chloride secretion (b). Cells are joined at the apical surface by tight junctions. In (a) sodium ions enter the cell through apical sodium channels and are pumped out of the basolateral surface by the sodium pump (P). Potassium ions cycle via the sodium pump and basolateral K channels. In (b) chloride ions enter the cell by a basolaterally located carrier (C) along with potassium and sodium ions. The latter two are dealt with by the pump and potassium channels as before. Chloride ions leave through the apical surface via chloride channels sensitive to cyclic AMP. Counterions, chloride in (a) and sodium in (b), move through paracellular pathways. A-amiloride.
particularly in the more proximal regions, effect fluid absorption? Two types of transporting mechanism are depicted in figure 2- Normally electrogenic chloride secretion is not present in respiratory epithelium, but it can be activated by beta agonists and other agents that increase intracellular cyclic AMP, prostaglandins, and bradykinin. The first step in chloride secretion requires that chloride is accumulated in the cell to a level greater than expected from the elctrochemical gradient. The cell does this by using a sodium-potassium chloride cotransporter with the stoichiometry Na+: K+: Cl-1: 1:2 (fig 2b) . The energy stored in the electrochemical gradient for sodium between the outside of the cell and the interior provides the energy source for driving potassium and chloride uphill into the cell. The sodium and potassium ions that enter the cell along with chloride are dealt with by the sodium pump and by equilibration through basolateral K+ channels respectively. Chloride is then free to move out of the cell, across the apical membrane, and down its electrochemical gradient, provided that the chloride channels are open. Agents that increase cyclic AMP increase the open state probability of these channels. Thus the processes of chloride secretion lead to a transfer of charge (anions) across the tissue such that a favourable gradient for accompanying countercation movement is generated. The main counterions will be sodium ions moving mainly through paracellular routes.
Both the absorptive and secretory processes that have been described will influence water movement, inwards and outwards respectively, across the epithelium. This is possible because respiratory epithelium is water permeable. This is not so for epithelia with low water permeability (for example, sweat duct), where salts can be absorbed without consequent fluid movement. The presence in the pulmonary system of these transport processes, with a predominant, unregulated absorptive process plus a secretory process that can be activated and regulated by autacoids and transmitters, provides the opportunity for fine tuning of the thickness of the fluid (sol) phase lining the proximal airways. The control of the thickness of the fluid lining has not been definitely demonstrated, but it is known that both these processes are present in epithelium lining the proximal airways and, more importantly, how they are modified in cystic fibrosis.
Abnormalities of epithelial ion transport in cystic fibrosis
The first insightful observation in relation to the transport function in cystic fibrosis airway epithelium was that the potential difference across the nasal mucosa and bronchi of patients with cystic fibrosis was around twice that of subjects not suffering from cystic fibrosis.8 On its own this result is difficult to interpret because either increased sodium absorption or reduced chloride conductance at the apical surface would give this result.
When amiloride is superfused into the apical surface of nasal epithelia in vivo the potential It is, however, possible that raised Cai activates basolateral K+ channels, leading to hyperpolarisation of the apical membrane, thus increasing the electrochemical potential for efflux, even though the membrane has a low chloride conductance. Figure 3 provides a summary of the comparisons in transporting properties between cystic fibrosis and normal respiratory epithelium, plus the effects of different types of secretagogues.
Possible consequences of transporting abnormalities in cystic fibrosis Mucociliary clearance depends on the functioning of cilia within the sol phase lining the respiratory passages. Not only is fluid moved toward the proximal airways but mucus and entrapped foreign particles are moved to a position from which they can be eliminated from the lung. Excessive solute transport out of the airways, with consequent fluid absorption, may reduced the sol phase, depositing thick, viscid mucus on the cilia. Mucus deposits are difficult to dislodge and provide a breeding ground for Staphylococus aureus and Pseudomonas aeruginosa. Although this is a reasonable hypothesis there is little definitive evidence to support it. The reason is a technical one-it is difficult to sample fluid from the airways without evaporative losses, making accurate determination of composition very difficult.
The chemical composition of secreted mucus is known to be altered in cystic fibrosis, with increased sulphation of high molecular weight glycoconjugates.20 As cystic fibrosis is a single gene defect it becomes increasingly difficult to explain how properties as diverse as mucus composition and chloride conductance are related to a single abnormal form of the cystic fibrosis transmembrane regulator, though abnormal chloride transport may increase the concentration of intracellular sulphate and increase substrate driven sulphation of glycoproteins. Two groups have reported their findings on chloride channels in airway epithelial cells using the patch clamp technique.2 22 In the cell attached configuration chloride channels were rarely seen unless the cell was activated by agents that increased cAMP. After stimulation there was an increased probability of chloride channel opening in normal cells (fig 5c) but not in cystic fibrosis cells (fig 5d) . Again with the cell attached configuration, the calcium ionophore A23187 was able to activate chloride channels in both normal and cystic fibrosis cells. Isolated patches from cells activated by cAMP generating secretagogues showed chloride channel activity (fig 5ei) , whereas patches from similarly therefore cannot be related to the infected conditions in cystic fibrosis airways. Secondly, apical membrane chloride channels incorporated into lipid bilayers show properties similar to those in normal membranes, but undergo a rapid run down. Activity can be restored by addition of the phosphorylating "cocktail" including the catalytic subunit of protein kinase A, indicating that a phosphorylation event is concerned in the functioning of airway chloride channels.27 Protein kinase C can also activate chloride channels in airway epithelial cells, but again regulation by this kinase is defective in cystic fibrosis. 28 Whatever method has been used to activate cystic fibrosis chloride channels in vitro their properties have proved to be identical to those of normal channels-that is, conductance of around 50 pS at 0 mv, an outwardly rectifying current-voltage relationship, and a Cl-to Na+ selectivity ratio of 10:1.
Far less is known about sodium channel mechanisms in airway cells. The mean channel lifetime for sodium channels in cystic fibrosis cells is twice that ofnormal channels, providing a correlate for the increased sodium reabsorption in cystic fibrosis.29 It has also been shown that the macroscopic Kd for amiloride is increased and there is an altered relation between sodium concentration and sodium transport in cystic fibrosis epithelium.'0 These latter studies were made with sweat duct epithelium, however, not airway epithelium. Nevertheless, a picture is emerging of altered molecular characteristics affecting both chloride and sodium channels in cystic fibrosis. From the patch clamp data it is difficult to argue that the sodium channel effects are a result of aberrant chloride transport, yet both alterations in channel properties are a consequence of a single gene defect.
Future therapeutic strategies An experiment that many must now be attempting is to transfect various cells with the cDNA for cystic fibrosis transmembrane regulator. This approach may show whether or not the cystic fibrosis transmembrane regulator is the chloride channel. This seems a little unlikely as altered sodium channel characteristics are retained in isolated patches. More probably it will be shown that transfection of cystic fibrosis cells with the cystic fibrosis transmembrane regulator cDNA will correct the ion channel abnormalities. In the long term transfection of airway epithelium in patients with cDNA in a retrovirus vector may be possible. Insufflation of the appropriate material into the respiratory tract may be easily arranged and considerable improvement might be envisaged even from transfection of only a fraction of the affected cells. Major obstacles need to be overcome before ethical permission is likely to be given, not the least of which is the possibility of switching on cellular oncogenes.
An alternative approach is to correct the transport irregularities with agents active from the apical surface. Nebulisation provides a route of administration that is likely to confine the pharmacological effect to the airways. Amiloride, an epithelial sodium channel blocker, is an obvious candidate and has been tried.3' Fourteen volunteer adults with cystic fibrosis took part in a study in which amiloride solution or control vehicle was administered by nebuliser in a double blind crossover study with two 25 week treatment periods. The mean (SEM) loss in forced vital capacity was reduced significantly from 3-4 (1 1) ml/day with vehicle to 1-4 (07) 
Summary
Details of ion transporting abnormalities in cystic fibrosis airway epithelium are now known. The central hypothesis, that excessive drying of the airway surfaces is a primary event that leads to all the manifestations of the respiratory insufficiency in cystic fibrosis, is not proved. The hypothesis is, however, consistent with the known transporting abnormalities and is strengthened by the modest clinical improvement produced by a strategy designed to correct the transporting abnormalities. The discovery of the cystic fibrosis gene, together with the presumed structure of the protein product, provides a focal point that must eventually connect the functional abnormalities with the genetic defect. The cellular function of the cystic fibrosis transmembrane regulator must now be the major target in research on cystic fibrosis. Strategies for treatment based on known cellular and molecular abnormalities are beginning to emerge but will be undoubtedly more focused once the responsibility of the cystic fibrosis transmembrane regulator is known.
Addendum
Since this review was completed the prediction made under "Future therapeutic strategies" has been realised. Complementation studies have shown that the introduction of plasmids containing cystic fibrosis transmembrane regulator cDNA into cultured cystic fibrosis cells does indeed restore a chloride conductance response to cAMP.3839 Additionally, it now appears that the cystic fibrosis transmembrane regulator fails to be glycosylated in cystic fibrosis cells, being retained in the golgi and not transferred to the cell membrane.40 A plasma membrane location of the cystic fibrosis transmembrane regulator is consistent either with an MDR like function or with its being a direct regulator of ion channel activity.
